Related Experiment Videos
Intravenous nitroglycerin in acute myocardial infarction
Circulation
|January 1, 1975
Summary
Intravenous nitroglycerin improved left ventricular function and reduced myocardial ischemia in patients with acute myocardial infarction. This therapy may help preserve heart muscle and limit infarct size.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Vasodilator therapy can improve ventricular function in acute myocardial infarction.
- Sublingual nitroglycerin offers transient and variable benefits.
Purpose of the Study:
- To evaluate the effects of intravenous nitroglycerin on left ventricular function and myocardial ischemia in acute myocardial infarction.
Main Methods:
- Administered intravenous nitroglycerin to 12 patients with acute myocardial infarction.
- Monitored left ventricular filling pressure, mean arterial pressure, and stroke work index.
- Conducted serial precordial mapping studies to assess ST segment changes.
Main Results:
- Intravenous nitroglycerin significantly decreased left ventricular filling pressure (22 to 12 mm Hg) and mean arterial pressure (P < 0.05).
- Stroke work index remained unchanged, suggesting improved ventricular performance or compliance.
- Precordial mapping showed a significant decrease in ST segment elevation (P < 0.001) in all patients studied.
Conclusions:
- Intravenous nitroglycerin effectively improved left ventricular function and reduced myocardial ischemia in acute myocardial infarction.
- Longer infusions may preserve ischemic myocardium and limit infarct size.